> Skip repeated content
photo of Nancy Pan, MD

Nancy Pan, MD

Lerner Children's Pavilion at Hospital for Special Surgery logoPediatrics, Rheumatology
phone icon

About Dr. Pan


Dr. Pan specializes in the care and treatment of children with rheumatic diseases including juvenile idiopathic arthritis, juvenile dermatomyositis, childhood systemic lupus and vasculitides of childhood. Dr. Pan is the site Principal Investigator for the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) and helps lead the quality improvement efforts in the Division of Pediatric Rheumatology at Hospital for Special Surgery. Dr. Pan is also a principal investigator in international clinical trials in juvenile idiopathic arthritis and has funding through the Childhood Arthritis and Rheumatology Research Alliance (CARRA).

Dr. Pan received her medical degree from New York University School of Medicine and completed her residency in Pediatrics at New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Pan then completed her fellowship in Pediatric Rheumatology at Hospital for Special Surgery. During her fellowship, Dr. Pan pursued clinical and translational research identifying biomarkers for flares in lupus as a part of the Mary Kirkland Center for Lupus Care. Dr. Pan is board-certified by the American Board of Pediatrics in Pediatrics and Pediatric Rheumatology.


Special Expertise

Childhood arthritis, childhood systemic lupus erythematosus, Vasculitis diseases of childhood, systemic sclerosis, juvenile dermatomyositis 

Patient Stories


Patient ratings for Dr. Pan


Learn more about our patient ratings.


If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.



Assistant Attending Pediatrician, Hospital for Special Surgery
Assistant Professor of Pediatrics, Weill Cornell Medical College


American College of Rheumatology
American Academy of Pediatrics
American Academy of Pediatrics, Section on Rheumatology
Childhood Arthritis and Rheumatology Research Alliance (CARRA)
Arthritis Providers and Researchers Advocacy Alliance


American Board of Pediatrics
Pediatric Rheumatology


MD, New York University School of Medicine, New York, NY


NewYork Presbyterian Hospital - Weill Cornell Medical Center, New York, NY


NewYork Presbyterian Hospital - Weill Cornell Medical Center, New York, NY


Hospital for Special Surgery, New Yok, NY

State Licensure


English, Mandarin Chinese

For My Patients

Publications by Dr. Pan

Selected Journal Articles

Selected Presentations

Walters H, Pan N, Moorthy LN, Ward, MJ, Peterson, M, Lehman TJ. Pediatric Systemic Lupus Erythematosus: Familial Inheritance, Severity, and Gender Comparisons. Pediatric Academic Societies Denver, CO 2011

Mertelsmann-Voss C, Kalliolias G.D, Pan N, Lehman TJ. A Novel Mutation in the TNFRSF1A gene identified in a 3 month old male with periodic fever heterozygous for the E148Q variant of MEFV gene. European League Against Rheumatism   Annual European Congress of Rheumatology, London 2011

Jacek, Elzbieta E., Olferiev, Mikhail, Domingues, Vinicius, Duculan, Rolando, Pan, Nancy, Crow, Mary K., et al; Mucocutaneous Flares As Opposed to Flares From Other Organs Have the Strongest Association with High Type I Interferon Levels in Patents with Systemic Lupus Erythematosus. [abstract]. Arthritis Rheum 2011;63 Suppl 10 :1807.
Poster Presentation. American College of Rheumatology Annual Scientific Meeting. Chicago 2011

Pan, Nancy, Amigues, Isabelle, Duculan, Rolando, Aziz, Faiza, Lyman, Stephen L., Crow, Mary K., et al; Rapid Surges of Anti-dsDNA Titers Predict Severe Clinical Flares in Systemic Lupus Erythematosus. [abstract]. Arthritis Rheum 2011;63 Suppl 10 :1709.
ORAL PRESENTATION American College of Rheumatology Annual Scientific Meeting. Chicago 2011


Research Interests

Juvenile idiopathic arthritis, systemic lupus erythematosus

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

As of March 24, 2023, Dr. Pan reported no relationships with the healthcare industry.

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.

Dr. Pan in the News